Tools for dissecting signaling pathways in vivo: receptors activated solely by synthetic ligands.
- 1 January 2002
- journal article
- Published by Elsevier
- Vol. 343, 232-248
- https://doi.org/10.1016/s0076-6879(02)43139-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Engineering receptors activated solely by synthetic ligands (RASSLs)Trends in Pharmacological Sciences, 2001
- Unnatural Ligands for Engineered Proteins: New Tools for Chemical GeneticsAnnual Review of Biophysics, 2000
- Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic miceNature Biotechnology, 1999
- Mapping the receptor domains critical for the binding selectivity of δ-opioid receptor ligandsEuropean Journal of Pharmacology, 1996
- Characterization of Irreversible Binding of β-Funaltrexamine to the Cloned Rat μ Opioid ReceptorPublished by Elsevier ,1995
- Diuretic Effects, Pharmacokinetics, and Safety of a New Centrally Acting Kappa‐Opioid Agonist (CI‐977) in HumansThe Journal of Clinical Pharmacology, 1994
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- The cardiovascular and central nervous system effects in the human of U-62066EEuropean Journal of Clinical Pharmacology, 1994
- Receptor-Effector Coupling by G Proteins: Implications for Normal and Abnormal Signal TransductionEndocrine Reviews, 1992
- κ-Opioid receptors and analgesiaTrends in Pharmacological Sciences, 1990